Introduction of clusterin gene into human renal cell carcinoma cells enhances their resistance to cytotoxic chemotherapy through inhibition of apoptosis both in vitro and in vivo

Japanese Journal of Cancer Research

Volumn 92, Issue 11, 2001, Pages 1220-1224

  Hara, Isao ^a   Miyake, Hideaki ^a,b   Gleave, Martin E ^b   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Chemotherapy; Clusterin; Renal cell carcinoma

Indexed keywords

CISPLATIN; CLUSTERIN; CYTOTOXIC AGENT; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL DEATH; CONTROLLED STUDY; DNA DETERMINATION; EXPRESSION VECTOR; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 0035213607     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb02143.x     Document Type: Article

References (20)

1. Prognostic factors in renal cell carcinoma
2. Expressions of tumor-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma
3. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: No evidence for prognostic significance
4. P53, bcl-2, and Bax expression in renal cell carcinoma
5. Expression of bcl-2, p53 oncoprotein, and proliferating nuclear antigen in renal cell carcinoma
6. Clusterin: Physiologic and pathophysiologic considerations
7. SGP-2 expression as a genetic marker of progressive cellular pathology in experimental hydronephrosis
8. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation
9. Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus
10. Prevention of cell death induced by tumor necrosis factor α in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin)
11. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen-independence in prostate cancer
12. Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene, testosterone-repressed prostate message-2, in prostate cancer xenograft models
13. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo
14. Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting antiapoptotic genes up-regulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity
15. Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal cell carcinomas
16. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxy-nucleotides
17. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
18. Urinary tract obstruction
19. Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury
20. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties